Aleksoto medicinos konsultacijų centras, VšĮ - financials and debts
Company age: 19 y. 4 mo.
Aleksoto medicinos konsultacijų centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 44,568 | 79,211 | 134,178 | 327,579 | 456,401 | 549,025 | 637,316 |
| Profit before tax | - | - | - | - | 30,517 | 64,720 | 60,055 | 54,026 |
| Net profit | - | - | - | - | 28,252 | 63,545 | 59,286 | 43,440 |
| Equity | 13,431 | 43,750 | 81,832 | 132,705 | 160,065 | 223,610 | 282,894 | 326,334 |
| Liabilities | 8,868 | 13,964 | 14,617 | 17,409 | 18,276 | 37,767 | 27,617 | 61,663 |
| Non-current assets | 11,984 | 13,862 | 58,434 | 44,438 | 59,506 | 59,398 | 91,083 | 132,596 |
| Current assets | 14,360 | 47,596 | 42,757 | 109,396 | 124,399 | 208,365 | 227,717 | 255,401 |
| Total assets | 26,344 | 61,458 | 101,191 | 153,834 | 183,905 | 267,763 | 318,800 | 387,997 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 62,388 | 69,421 | 72,858 |
| Social insurance contributions | - | - | - | - | - | 67,577 | 80,063 | 83,625 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +77.7% | +69.4% | +144.1% | +39.3% | +20.3% | +16.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 15.4% | 23.7% | 18.6% | 11.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 17.7% | 28.4% | 21.0% | 13.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 8.6% | 13.9% | 10.8% | 6.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 9.3% | 14.2% | 10.9% | 8.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.3 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 1,959 | 3,179 | 5,533 | 12,559 | 16,156 | 18,050 | 22,694 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Aleksoto medicinos konsultacijų centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-18 | 2024-11-20 | 5.82 |
| 2024-10-29 | 2024-11-12 | 6.09 |
| 2024-10-24 | 2024-10-27 | 6.09 |
| 2024-08-19 | 2024-08-21 | 8041.40 |
| 2024-04-23 | 2024-05-14 | 0.64 |
| 2023-05-02 | 2023-05-11 | 3.48 |
| 2023-04-25 | 2023-04-28 | 3.48 |
| 2023-02-06 | 2023-02-14 | 0.34 |
| 2023-01-23 | 2023-02-03 | 0.34 |
| 2023-01-17 | 2023-01-18 | 4141.53 |
| 2022-10-28 | 2022-11-14 | 5.06 |
| 2022-10-18 | 2022-10-19 | 899.43 |
| 2022-07-18 | 2022-07-18 | 4219.75 |
| 2022-01-27 | 2022-02-14 | 0.80 |
Aleksoto medicinos konsultacijų centras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Aleksoto medicinos konsultaciju centras, VšI (code 300845517) is a Public Institution operating in medical specialists activities. In 2025, revenue reached €637.3K, up 16.1% year on year and 39.6% over two years, showing continued top-line expansion from €456.4K in 2023 and €549.0K in 2024. Net profit was €43.4K in 2025, compared with €59.3K in 2024 and €63.5K in 2023, so profitability softened despite higher sales. The profit margin declined to 6.8% from 10.8% in 2024 and 13.9% in 2023. At year-end 2025, total assets stood at €388.0K, equity at €326.3K and liabilities at €61.7K. The balance sheet remained strongly equity-funded, with an equity ratio of 84.1% and debt-to-equity of 0.19. Asset turnover was 1.64x, while ROE was 13.3% and ROA 11.2%. Revenue per employee was €22.8K and profit per employee €1.6K.